VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
Varey, A H R ; Rennel, E S ; Qiu, Y ; Bevan, H S ; Perrin, R M ; Raffy, S ; Dixon, A R ; Paraskeva, C ; Zaccheo, O ; Hassan, A B ; Harper, S J ; Bates, D O
British journal of cancer, 2008-04, Vol.98 (8), p.1366-1379 [Periódico revisado por pares]England
Texto completo disponível